Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
Background Systemic sclerosis (SSc) is a severe, progressive multiorgan disease but to date, there are no established standardised international guidelines for follow-up of patients with SSc. The goal of this project was to develop an expert consensus for annual systematic investigations in patients...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-05-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/5/1/e000826.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850213291644682240 |
|---|---|
| author | Yannick Allanore Dinesh Khanna Oliver Distler Anna-Maria Hoffmann-Vold Baron Murray Otylia Kowal-Bielecka |
| author_facet | Yannick Allanore Dinesh Khanna Oliver Distler Anna-Maria Hoffmann-Vold Baron Murray Otylia Kowal-Bielecka |
| author_sort | Yannick Allanore |
| collection | DOAJ |
| description | Background Systemic sclerosis (SSc) is a severe, progressive multiorgan disease but to date, there are no established standardised international guidelines for follow-up of patients with SSc. The goal of this project was to develop an expert consensus for annual systematic investigations in patients with SSc to enhance their standard-of-care.Material and methods The Delphi method was applied. All SSc experts from the European Scleroderma Trials and Research group network and the Scleroderma Clinical Trial Consortium were invited to participate. All experts were asked to answer questionnaires in five Delphi steps to determine the domains of interest and tools for each domain for an annual systematic assessment of patients with SSc. Each item was rated on a scale between 0% and 100% (not and very important), and parameters rated >80% by more than 75% of the experts were regarded as acceptable.Results In total, 157 experts worldwide participated with 71.3% experts seeing >50 patients with SSc annually. In the first round, 23 domains and 204 tools were suggested. After five Delphi steps, experts agreed on 10 domains including (1) Raynaud’s phenomenon; (2) Digital ulcers; (3) Skin and mucosa; (4) Lung; (5); Heart; (6) GI domain, (7) Renal; (8) Musculoskeletal; (9) Laboratory and (10) Treatment. Overall, 55 tools were identified including clinical assessments, laboratory measurements and imaging or functional investigations.Conclusion Through five Delphi steps with world leading experts, a consensus was established on strongly suggested tools for a minimum annual systemic assessment of organ involvement in SSc. This work should enhance the standardisation and homogenisation of the practices. |
| format | Article |
| id | doaj-art-31cf9bb4be26411aa7c7ba2042a842cd |
| institution | OA Journals |
| issn | 2056-5933 |
| language | English |
| publishDate | 2019-05-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | RMD Open |
| spelling | doaj-art-31cf9bb4be26411aa7c7ba2042a842cd2025-08-20T02:09:09ZengBMJ Publishing GroupRMD Open2056-59332019-05-015110.1136/rmdopen-2018-000826Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical featuresYannick Allanore0Dinesh Khanna1Oliver Distler2Anna-Maria Hoffmann-Vold3Baron Murray4Otylia Kowal-Bielecka5Department of Rheumatology A, Université Paris Descartes, Faculté de Médecine, Paris, FranceDepartment of Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USADepartment of Rheumatology, University Hospital Zurich, Zurich, SwitzerlandDepartment of Rheumatology, Oslo University Hospital, Oslo, Norway3 Rheumatology, Jewish General Hospital, Montreal, Quebec, CanadaDepartment of Rheumatology and Internal Medicine, Medical University of Bialystok, Bialystok, PolandBackground Systemic sclerosis (SSc) is a severe, progressive multiorgan disease but to date, there are no established standardised international guidelines for follow-up of patients with SSc. The goal of this project was to develop an expert consensus for annual systematic investigations in patients with SSc to enhance their standard-of-care.Material and methods The Delphi method was applied. All SSc experts from the European Scleroderma Trials and Research group network and the Scleroderma Clinical Trial Consortium were invited to participate. All experts were asked to answer questionnaires in five Delphi steps to determine the domains of interest and tools for each domain for an annual systematic assessment of patients with SSc. Each item was rated on a scale between 0% and 100% (not and very important), and parameters rated >80% by more than 75% of the experts were regarded as acceptable.Results In total, 157 experts worldwide participated with 71.3% experts seeing >50 patients with SSc annually. In the first round, 23 domains and 204 tools were suggested. After five Delphi steps, experts agreed on 10 domains including (1) Raynaud’s phenomenon; (2) Digital ulcers; (3) Skin and mucosa; (4) Lung; (5); Heart; (6) GI domain, (7) Renal; (8) Musculoskeletal; (9) Laboratory and (10) Treatment. Overall, 55 tools were identified including clinical assessments, laboratory measurements and imaging or functional investigations.Conclusion Through five Delphi steps with world leading experts, a consensus was established on strongly suggested tools for a minimum annual systemic assessment of organ involvement in SSc. This work should enhance the standardisation and homogenisation of the practices.https://rmdopen.bmj.com/content/5/1/e000826.full |
| spellingShingle | Yannick Allanore Dinesh Khanna Oliver Distler Anna-Maria Hoffmann-Vold Baron Murray Otylia Kowal-Bielecka Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features RMD Open |
| title | Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features |
| title_full | Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features |
| title_fullStr | Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features |
| title_full_unstemmed | Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features |
| title_short | Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features |
| title_sort | setting the international standard for longitudinal follow up of patients with systemic sclerosis a delphi based expert consensus on core clinical features |
| url | https://rmdopen.bmj.com/content/5/1/e000826.full |
| work_keys_str_mv | AT yannickallanore settingtheinternationalstandardforlongitudinalfollowupofpatientswithsystemicsclerosisadelphibasedexpertconsensusoncoreclinicalfeatures AT dineshkhanna settingtheinternationalstandardforlongitudinalfollowupofpatientswithsystemicsclerosisadelphibasedexpertconsensusoncoreclinicalfeatures AT oliverdistler settingtheinternationalstandardforlongitudinalfollowupofpatientswithsystemicsclerosisadelphibasedexpertconsensusoncoreclinicalfeatures AT annamariahoffmannvold settingtheinternationalstandardforlongitudinalfollowupofpatientswithsystemicsclerosisadelphibasedexpertconsensusoncoreclinicalfeatures AT baronmurray settingtheinternationalstandardforlongitudinalfollowupofpatientswithsystemicsclerosisadelphibasedexpertconsensusoncoreclinicalfeatures AT otyliakowalbielecka settingtheinternationalstandardforlongitudinalfollowupofpatientswithsystemicsclerosisadelphibasedexpertconsensusoncoreclinicalfeatures |